Trial Profile
Match-up of two once weekly GLP-1 receptor agonists (exenatide,dulaglutide) about efficacy and satisfaction
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 21 Jan 2019
Price :
$35
*
At a glance
- Drugs Dulaglutide (Primary) ; Exenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 16 Jan 2019 Status changed from not yet recruiting to discontinued.
- 02 Aug 2016 New trial record